Diana Isabel Sánchez Paniagua-rekin lankidetzan egindako argitalpenak (8)

2018

  1. Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells

    Frontiers in Pharmacology, Vol. 9, Núm. MAY

  2. Melatonin modulates dysregulated circadian clocks in mice with diethylnitrosamine-induced hepatocellular carcinoma

    Journal of Pineal Research, Vol. 65, Núm. 3

2017

  1. Effects of oral glutamine on inflammatory and autophagy responses in cancer patients treated with abdominal radiotherapy: A pilot randomized trial

    International Journal of Medical Sciences, Vol. 14, Núm. 11, pp. 1065-1071

  2. Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells

    BioFactors, Vol. 43, Núm. 2, pp. 272-282

  3. Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma

    Journal of Pineal Research, Vol. 62, Núm. 1

  4. Sphingosine 1-phosphate signaling as a target in hepatic fibrosis therapy

    Frontiers in Pharmacology, Vol. 8, Núm. AUG

2016

  1. Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin

    Journal of Pineal Research, pp. 168-176

2015

  1. Melatonin inhibits autophagy and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis

    Journal of Pineal Research, Vol. 59, Núm. 2, pp. 151-162